3D in-vitro models and organ-on-a-chip technologies are paving the way to the next revolution in drug discovery and predictive medicine. Learn more about these technologies and how they are used by pharma leaders.
CSEM and its partners Toolpoint for Lab Science and the University of Basel put together an exciting day with four keynote speakers and six innovation pitches. Come and listen to world-class speakers talking about the latest advances in this field.
- Stefan Platz, AstraZeneca
- Jochen Kühnl, Beiersdorf
- Dr. Peter Loskill, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB
- Hansjörg Keller, Novartis Institutes for BioMedical Research
Innovation leaders such as InSphero, Mimetas, TissUse, BI/OND, CellSpring, ETHZ and CSEM will share insights about their latest technologies.
10.00 – 15.55
Organ-on-a-Chip systems: Integrated microphysiological platforms recapitulating complex human biology
Prof. Dr. Peter Loskill (Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, DE)
Tissue engineering of functional human skeletal muscle models for drug screening using 3D bioprinting
Dr. Hansjörg Keller (Novartis Institutes for BioMedical Research, Basel, CH)
Parallelized long term monitoring of 3D tissues
Dr. Vincent Revol (CSEM, Alpnach, CH)
Dr. Oliver Frey (Insphero, Schlieren, CH)
Next generation cell culture: Enhancing tissue complexity in perfused microfluidic chips
Dr. Paul Vulto (Mimetas, Leiden, NL)
BI/OND: Versatile Organ-on-Chip Platform
Dr. Nikolas Gaio (BI/OND, Delft, NL)
Lunch break & Industry Symposia
Microfluidic cell cultivation and analysis
Prof. Dr. Petra Dittrich (ETHZ Basel, Department of Biosystems Science and Engineeringm Basel, CH)
3D Cell Culture for Discovery of Prostate Cancer Biomarkers for Liquid Biopsy Diagnostics
Dr. Chris Millan (CellSpring, Schlieren, CH)
Applying Multi-Organ-Chip Technology in Safety and Efficacy Testing: How far have we come?
Dr. Reyk Horland (TissUse, Berlin, DE)
Applications of renal and cardiovascular models in drug discovery
Dr. Stefan Platz (AstraZeneca, UK/CH)
Case studies for the characterisation of chemical metabolism in a microphysiological system combining skin and liver organ models
Dr. Jochen Kühnl (Beiersdorf AG, Hamburg, DE)